INTERNATIONAL PATENT: NEURIMMUNE AG FILES APPLICATION FOR "MAINTENANCE TREATMENT OF CARDIAC TTR AMYLOIDOSIS USING ANTI-TRANSTHYRETIN ANTIBODIES"

GENEVA, Nov. 24 -- NEURIMMUNE AG (Wagistrasse 188952 Schlieren) filed a patent application (PCT/EP2025/063386) for "MAINTENANCE TREATMENT OF CARDIAC TTR AMYLOIDOSIS USING ANTI-TRANSTHYRETIN ANTIBODIES" on May 15, 2025. With publication no. WO/2025/238147, the details related to the patent application was published on Nov 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MICHALON, Aubin (Martinsbergstrasse 365400 Baden), KAHR, Peter (Zurichbergstrasse 208032 Zurich)

Abstract: Provided is a maintenance therapy for TTR amyloidosis in a subject.

For more information:https://patentscope.wipo....